Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Chronic Myeloid Leukemia Clinical Trials
Chronic Myeloid Leukemia clinical trials are recruiting across 48 cities. Here are the cities with the most active studies:
Chronic Myeloid Leukemia Trial Phases
18 research organizations are sponsoring chronic myeloid leukemia trials.
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.
Clinical trials are advancing new treatments for chronic myeloid leukemia. Currently, 35 studies are recruiting a combined 7,777 participants across the United States. Research is being conducted by 18 organizations including M.D. Anderson Cancer Center, Novartis Pharmaceuticals, Pfizer and 15 others.
2026 Chronic Myeloid Leukemia Research Landscape
As of July 2026, the chronic myeloid leukemia clinical trial landscape includes 35 actively recruiting studies across 48 cities in the United States. These studies are collectively seeking 7,777 participants, with an average enrollment target of 222 per study.
The research spans multiple phases of development: 20 studies are in PHASE2, 13 studies are in PHASE1, 1 study is in PHASE4, 1 study is in PHASE3, 1 study is in NA. The presence of Phase 3 trials indicates that some chronic myeloid leukemia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 18 different organizations, including M.D. Anderson Cancer Center, Novartis Pharmaceuticals, Pfizer, Ascentage Pharma Group Inc., Enliven Therapeutics, and 13 others. The large number of sponsors reflects significant research interest and investment in chronic myeloid leukemia treatment advancement.
Geographically, chronic myeloid leukemia trials are most concentrated in Houston, Texas (17 trials); New York, New York (8 trials); Birmingham, Alabama (4 trials); Milwaukee, Wisconsin (3 trials); Salt Lake City, Utah (3 trials) and 7 other cities.
Featured Chronic Myeloid Leukemia Studies
Highlighted recruiting studies for chronic myeloid leukemia, selected by enrollment size and research scope.
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
In this study researchers propose to do a chart review of all patients that are treated outside of a clinical trial with imatinib, dasatinib, nilotinib, or any other tyrosine kinase inhibitor that becomes FDA approved for the managements of CML that come to MDACC for a second opinion. This is an important population of patients that differs in their management from patients treated in clinical tri...
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
This CML disease registry (ASC4REAL-2) aims to gather evidence on the tolerability, safety, effectiveness, and patient-reported outcomes (PRO) in real-world healthcare from patients with Ph+-CML-CP treated with TKIs approved for 1L and 2L, including prospective follow-up for 5 years identifying and describing long-term treatment outcomes.
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
The purpose of this study is to look at how safe and effective is bosulif in routine clinical practice. This study is seeking for participants who are: 1. Patients who are being treated\* or will be treated with Bosulif according to it's local product document under routine clinical practice (\*Patients who initiated Bosulif treatment within one year before consent) 2. Evidence of a personally s...
Frequently Asked Questions About Chronic Myeloid Leukemia Clinical Trials
Are there chronic myeloid leukemia clinical trials near me?
Yes, there are 35 chronic myeloid leukemia clinical trials currently recruiting across 48+ cities in the United States, including Houston, Texas; New York, New York; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a chronic myeloid leukemia clinical trial?
To join a chronic myeloid leukemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are chronic myeloid leukemia clinical trials free?
Yes, participation in chronic myeloid leukemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of chronic myeloid leukemia treatments are being studied?
Current chronic myeloid leukemia clinical trials are testing a range of approaches across PHASE2 (20 studies), PHASE1 (13 studies), PHASE4 (1 study), PHASE3 (1 study), NA (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 18 research organizations.
Is it safe to participate in chronic myeloid leukemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov